Sector Highlight: Biotechnology ETFs
August 26th at 7:30am by Tom Lydon
Biotechnology exchange traded funds (ETFs) are moving higher this morning after speculation that GlaxoSmithKline (GSK) could make an offer to take over Human Genome Sciences (HGSI). Here are more stories on the subject that may interest you: